SEGMENTECTOMY/WEDGE resection following neoadjuvant/induction immunochemotherapy in non–small cell lung cancer: Is it justified?

IF 4.7 1区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Journal of Thoracic and Cardiovascular Surgery Pub Date : 2025-08-01 Epub Date: 2025-02-07 DOI:10.1016/j.jtcvs.2024.12.026

Hongsheng Deng MD , Ziwen Yu MD , Yue Pan MD , Ying Huang MD , Yu Jiang MD , Yuechun Lin MD , Runchen Wang MD , Jianqi Zheng MD , Junguo Dong MD , Chao Yang MD , Xin Xu MD , Wenhua Liang MD , Jianxing He MD, PhD, FACS , Hengrui Liang MD

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

非小细胞肺癌新辅助/诱导免疫化疗后的节段切除术/楔形切除术：是否合理？

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Journal of Thoracic and Cardiovascular Surgery 医学-呼吸系统

CiteScore

11.20

自引率

10.00%

发文量

1079

审稿时长

68 days

期刊介绍： The Journal of Thoracic and Cardiovascular Surgery presents original, peer-reviewed articles on diseases of the heart, great vessels, lungs and thorax with emphasis on surgical interventions. An official publication of The American Association for Thoracic Surgery and The Western Thoracic Surgical Association, the Journal focuses on techniques and developments in acquired cardiac surgery, congenital cardiac repair, thoracic procedures, heart and lung transplantation, mechanical circulatory support and other procedures.